Sompo Asset Management Co. Ltd. Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Sompo Asset Management Co. Ltd. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,280 shares of the healthcare conglomerate’s stock after acquiring an additional 20 shares during the period. Sompo Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $1,161,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Transatlantique Private Wealth LLC increased its position in shares of UnitedHealth Group by 9.9% in the 2nd quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate’s stock valued at $1,291,000 after acquiring an additional 234 shares during the period. Summit Trail Advisors LLC lifted its holdings in shares of UnitedHealth Group by 33.3% during the second quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate’s stock worth $6,115,000 after purchasing an additional 2,999 shares during the period. Columbus Hill Capital Management L.P. purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $14,789,000. Garden State Investment Advisory Services LLC boosted its holdings in shares of UnitedHealth Group by 13.5% in the 2nd quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate’s stock valued at $536,000 after acquiring an additional 125 shares during the last quarter. Finally, Pacer Advisors Inc. raised its holdings in shares of UnitedHealth Group by 5.7% during the second quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock worth $33,540,000 after purchasing an additional 3,525 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on UNH. TD Cowen increased their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Royal Bank of Canada boosted their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Barclays lifted their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Monday, September 16th. Finally, Truist Financial upped their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $614.17.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.4 %

Shares of UNH stock opened at $575.00 on Friday. The stock’s fifty day moving average is $577.10 and its two-hundred day moving average is $520.47. The firm has a market capitalization of $530.97 billion, a P/E ratio of 35.15, a PEG ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.14 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.